17th June China Covid-19 vaccine:
China's Sinopharm touts 100% antibody response for COVID-19 vaccine it's already giving to workers.

17th June China Covid-19 vaccine:
China's Sinopharm touts 100% antibody response for COVID-19 vaccine it's already giving to workers.

17th June China Covid-19 vaccine:
China's Sinopharm touts 100% antibody response for COVID-19 vaccine it's already giving to workers.

17th June China Covid-19 vaccine:
China's Sinopharm touts 100% antibody response for COVID-19 vaccine it's already giving to workers.

Many new models being introduced starting from this special incentive period. Job orders for Pecca will be strong.

Likely to test 70 sen by next week.

Latest quarter net profit also jumped few folds. This kind of business is very stable, even with covid-19.

Hexza will grow from strength to strength. As of end-2019, Hexza has RM62mil cash, RM99mil investments in securities, this means roughly 80sen per share, is very solid.

Business should be good. Egg price also stable.

Business is stable. Most brands its clients. Perodua key client.

didnt expect such poor results. Cut loss & took up Pecca while still cheap.

Car buyers choosing brands, Pecca is good. Irregard what brand, Pecca will be benefited from the tax incentives.

Price looks high to me, prefer Pecca for its attractive price & good return potential.

Car buyers choosing brands, Pecca is good. Irregard what brand, Pecca will be benefited from the tax incentives.

Result so bad! Cut loss, moved to Pecca.

Got chunks today. It will perform very well like Bursa as stock trading interest already spiked up.

Lately it has been upgraded to Shariah compliance status. We can expect huge capitals coming into Mtouche. Good upside.

with the new tax incentives, car sales will shoot up, positive for Pecca. Enter while still cheap. Others like UMW, MBMR, DRB all already moved up a lot, Pecca will soon follow.

this stock's potential return looks very good to me.

Run?

Strong buying interest. Think back to 40 sen wont be long.

Recent months trade volume very high. Bursa's coming QR will be very good. I think TP RM12 is achievable.

Haha now CIMB says not this quarter woh, see next quarter woh.

However, we believe that 3QFY20 did not capture the full impact of Covid-19 as it only began to hike ASPs aggressively from June 20.

Downtrend. Queued at 80 sen.

today will koyak? Tmr 7.5m shares at one-third price cashing out.

i smell blood in gpacket

Oh shit. 7mil additional shares coming tomorrow! Run now?

University of Oxford in England. A clinical trial with more than 500 participants began in late April. Oxford officials said the potential vaccine has an 80 percent chance for success and could be available as early as September

University of Oxford in England. A clinical trial with more than 500 participants began in late April. Oxford officials said the potential vaccine has an 80 percent chance for success and could be available as early as September

University of Oxford in England. A clinical trial with more than 500 participants began in late April. Oxford officials said the potential vaccine has an 80 percent chance for success and could be available as early as September

University of Oxford in England. A clinical trial with more than 500 participants began in late April. Oxford officials said the potential vaccine has an 80 percent chance for success and could be available as early as September

University of Oxford in England. A clinical trial with more than 500 participants began in late April. Oxford officials said the potential vaccine has an 80 percent chance for success and could be available as early as September

University of Oxford in England. A clinical trial with more than 500 participants began in late April. Oxford officials said the potential vaccine has an 80 percent chance for success and could be available as early as September

University of Oxford in England. A clinical trial with more than 500 participants began in late April. Oxford officials said the potential vaccine has an 80 percent chance for success and could be available as early as September.

huge selling pressure.

gosh, run so fast.

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries. The White House last month secured 300 million of the first doses of the potential vaccine.

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries. The White House last month secured 300 million of the first doses of the potential vaccine.

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries. The White House last month secured 300 million of the first doses of the potential vaccine.

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries. The White House last month secured 300 million of the first doses of the potential vaccine.

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries. The White House last month secured 300 million of the first doses of the potential vaccine.

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries. The White House last month secured 300 million of the first doses of the potential vaccine.

Hope it doesnt go back to 40 sen so soon.

Coronavirus (Covid-19) vaccine latest update: Oxford-AstraZeneca vaccine production starts; US says 2 billion doses ‘ready to go’
Coronavirus (Covid-19) Vaccine Latest Update: AstraZeneca plans to roll out two billion doses of Covid-19 vaccine in September; human trials of Australian vaccine next month

Coronavirus (Covid-19) vaccine latest update: Oxford-AstraZeneca vaccine production starts; US says 2 billion doses ‘ready to go’
Coronavirus (Covid-19) Vaccine Latest Update: AstraZeneca plans to roll out two billion doses of Covid-19 vaccine in September; human trials of Australian vaccine next month

Coronavirus (Covid-19) vaccine latest update: Oxford-AstraZeneca vaccine production starts; US says 2 billion doses ‘ready to go’
Coronavirus (Covid-19) Vaccine Latest Update: AstraZeneca plans to roll out two billion doses of Covid-19 vaccine in September; human trials of Australian vaccine next month

Coronavirus (Covid-19) vaccine latest update: Oxford-AstraZeneca vaccine production starts; US says 2 billion doses ‘ready to go’
Coronavirus (Covid-19) Vaccine Latest Update: AstraZeneca plans to roll out two billion doses of Covid-19 vaccine in September; human trials of Australian vaccine next month

Coronavirus (Covid-19) vaccine latest update: Oxford-AstraZeneca vaccine production starts; US says 2 billion doses ‘ready to go’
Coronavirus (Covid-19) Vaccine Latest Update: AstraZeneca plans to roll out two billion doses of Covid-19 vaccine in September; human trials of Australian vaccine next month

Coronavirus (Covid-19) vaccine latest update: Oxford-AstraZeneca vaccine production starts; US says 2 billion doses ‘ready to go’
Coronavirus (Covid-19) Vaccine Latest Update: AstraZeneca plans to roll out two billion doses of Covid-19 vaccine in September; human trials of Australian vaccine next month

can scgm cope with the high debt level? Most cash used to service interest?